Written answers
Thursday, 21 July 2016
Department of Health
Medicinal Products Reimbursement
Ruth Coppinger (Dublin West, Anti-Austerity Alliance)
Link to this: Individually | In context | Oireachtas source
429. To ask the Minister for Health further to Parliamentary Question No. 157 of 14 July 2016, when he expects the Health Service Executive to commence talks with the manufacturers of lumacaftor/ivacaftor (Orkambi); and if he will make a statement on the matter. [23372/16]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
As the HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013, I have arranged for the question to be referred to the HSE for direct reply to you. If you have not received a reply from the HSE within 15 working days, please contact my Private Office and they will follow up the matter with them.
No comments